A color-coded imaging model of the interaction of αv integrin-GFP expressed in osteosarcoma cells and RFP expressing blood vessels in Gelfoam® vascularized In Vivo

Anticancer Research

Volumn 33, Issue 4, 2013, Pages 1361-1366

  Uehara, Fuminari ^a,b,c   Tome, Yasunori ^a,b,c   Yano, Shuya ^a,b   Miwa, Shinji ^a,b   Mii, Sumiyuki ^a,b   Hiroshima, Yukihiko ^a,b   Bouvet, Michael ^b   Maehara, Hiroki ^c   Kanaya, Fuminori ^c   Hoffman, Robert M ^a,b  

^a ANTICANCER INC   (United States)

^b UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

^c UNIVERSITY OF THE RYUKYUS   (Japan)

Author keywords

v integrin; Blood vessels; Confocal microscopy; Gelfoam ; Green fluorescent protein; Osteosarcoma; Red fluorescent protein; Transgenic nude mouse

Indexed keywords

CD51 ANTIGEN; GREEN FLUORESCENT PROTEIN; RED FLUORESCENT PROTEIN;

ANGIOGENESIS; ANIMAL EXPERIMENT; ARTICLE; BLOOD VESSEL; CONFOCAL MICROSCOPY; FEMALE; FLUORESCENCE IMAGING; HUMAN; HUMAN CELL; IN VIVO STUDY; MOUSE; NONHUMAN; OSTEOSARCOMA CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; SKIN FLAP;

ANIMALS; BONE NEOPLASMS; DIAGNOSTIC IMAGING; FEMALE; GELATIN SPONGE, ABSORBABLE; GREEN FLUORESCENT PROTEINS; HUMANS; IMMUNOENZYME TECHNIQUES; INTEGRIN ALPHAV; LUMINESCENT PROTEINS; MICE; MICE, NUDE; MICE, TRANSGENIC; MICROSCOPY, FLUORESCENCE; NEOVASCULARIZATION, PATHOLOGIC; OSTEOSARCOMA; TUMOR CELLS, CULTURED;

EID: 84876759674     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (12)

1. Hynes RO: Integrins: Bidirectional, allosteric signaling machines. Cell 110: 673-687, 2002. (Pubitemid 35283958)
2. Stupack DG and Cheresh DA: Integrins and angiogenesis. Curr Top Dev Biol 64: 207-238, 2004. (Pubitemid 39752398)
3. Marshall JF and Hart IR: The role of áv-integrins in tumour progression and metastasis. Semin Cancer Biol 7: 129-138, 1996. (Pubitemid 26179260)
4. Tucker GC: áv integrin inhibitors and cancer therapy. Curr Opin Investig Drugs 4: 722-731, 2003.
5. Hood JD and Cheresh DA: Role of integrins in cell invasion and migration. Nat Rev Cancer 2: 91-100, 2002. (Pubitemid 37328796)
6. Duan X, Jia SF, Zhou Z, Langley RR, Bolontrade MF and Kleinerman ES: Association of ávâ3 integrin expression with the metastatic potential and migratory and chemotactic ability of human osteosarcoma cells. Clin Exp Metastatsis 21: 747-753, 2004.
7. Furukawa T, Kubota T and Hoffman RM: Clinical applications of the histoculture drug response assay. Clin Cancer Res 1: 305-311, 1995.
8. Kubota T, Sasano N, Abe O, Nakao I, Kawamura E, Saito T, Endo M, Kimura K, Demura H, Sasano H, Nagura H, Ogawa N and Hoffman RM: Potential of the histoculture drug response assay to contribute to cancer patient survival. Clin Cancer Res 1: 1537-1543, 1995. (Pubitemid 26028089)
9. Hoffman RM: Histocultures and their use. In: Encyclopedia of Life Sciences. John Wiley and Sons, Ltd.: Chichester, 2010, published online. DOI: 10.1002/9780470015902.a0002573.pub2.
10. Amoh Y, Li L, Katsuoka K, Bouvet M and Hoffman RM: GFPexpressing vascularization of Gelfoam® as a rapid in vivo assay of angiogenesis stimulators and inhibitors. BioTechniques 42: 294-298, 2007.
11. McCarty MF, Baker CH, Bucana CD and Fidler IJ: Quantitative and qualitative in vivo angiogenesis assay. Int J Oncol 21: 5-10, 2002.
12. Yang M, Reynoso J, Bouvet M and Hoffman RM: A transgenic red fluorescent protein-expressing nude mouse for color-coded imaging of the tumor microenvironment. J Cell Biochem 106: 279-284, 2009.